Joseph Mercola

July 25, 2022, Chinese officials granted conditional approval to Azvudine, an HIV drug, to be used as a COVID treatment.

Use of the HIV drug has reignited interest in early evidence suggesting SARS-CoV-2 is a bioweapon augmented with parts of the HIV virus.

… Several scenarios are now converging to create the suspicion that getting an HIV vaccine to market may be a goal behind COVID. The COVID jab is causing AIDS-like immunodepression, which helps create the perception that we have an urgent need for an HIV vaccine.